Enthesitis-related Arthritis

• CLINICAL_TRIALS research · 2026-02-27
  Clinical Trial Update: An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis [Phase 3]

  This is a Phase 3 open-label pharmacokinetics and safety study of bimekizumab in pediatric patients with Enthesitis-related arthritis and Ju…

• CLINICAL_TRIALS research · 2025-09-24
  Clinical Trial Update: Long Term Treatment Strategies and Effectiveness of Secukinumab in Patient With JIA Subtypes of JPsA and ERA: Study From German BIKER Registry.

  Clinical trial update on long-term treatment strategies and effectiveness of secukinumab in Enthesitis-related Arthritis and Juvenile Psoria…

• CLINICAL_TRIALS research · 2025-01-14
  Clinical Trial Update: Prospective Observational Study to Evaluate Secukinumab Treatment Effectiveness in Pediatric Patients With Active Juvenile Enthesitis-related or Psoriatic Arthritis

  A prospective observational study to evaluate the effectiveness of secukinumab in pediatric patients with active enthesitis-related arthriti…

• CLINICAL_TRIALS research · 2025-01-09
  Clinical Trial Update: A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.

  Registry study evaluating patient-reported outcomes, dosing patterns, and safety of Vunakizumab in several rheumatic diseases; recruitment h…

• CLINICAL_TRIALS research · 2024-04-25
  Clinical Trial Update: The Reliability and Validity of the Ankylosing Spondylitis Performance Index (ASPI) in Enthesitis-Related Arthritis

  This clinical trial evaluates the reliability and validity of the Ankylosing Spondylitis Performance Index (ASPI) in individuals with Enthes…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.